We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,406
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CODI icon
11426
Compass Diversified
CODI
$956M
$60.5K ﹤0.01%
3,225
-438
-12% -$9.21K
BKD icon
11427
CALL
Brookdale Senior Living
BKD
$3.02B
$60.4K ﹤0.01%
14,600
-31,200
-68% -$125K
TRAK icon
11428
CALL
ReposiTrak
TRAK
$155M
$60.4K ﹤0.01%
6,900
-13,500
-66% -$124K
TBPH icon
11429
CALL
Theravance Biopharma
TBPH
$881M
$60.4K ﹤0.01%
7,000
-3,800
-35% -$36.7K
WTFC icon
11430
CALL
Wintrust Financial
WTFC
$11B
$60.4K ﹤0.01%
800
-14,800
-95% -$1.16M
SRET icon
11431
CALL
Global X SuperDividend REIT ETF
SRET
$230M
$60.3K ﹤0.01%
3,000
-1,700
-36% -$36.6K
LVWR icon
11432
CALL
LiveWire
LVWR
$246M
$60.3K ﹤0.01%
8,700
+6,500
+295% +$69.2K
BNGO icon
11433
Bionano Genomics
BNGO
$13.9M
$60.3K ﹤0.01%
+332
New +$87K
SBSI icon
11434
CALL
Southside Bancshares
SBSI
$986M
$60.3K ﹤0.01%
2,100
+1,400
+200% +$41.7K
GHI icon
11435
PUT
Greystone Housing Impact Investors LP
GHI
$141M
$60.3K ﹤0.01%
3,933
-218
-5% -$3.46K
SEIC icon
11436
PUT
SEI Investments
SEIC
$12.8B
$60.2K ﹤0.01%
1,000
CHRS icon
11437
CALL
Coherus Oncology
CHRS
$185M
$60.2K ﹤0.01%
16,100
-23,300
-59% -$108K
FDIS icon
11438
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.72B
$60.1K ﹤0.01%
861
-1,387
-62% -$102K
PRCH icon
11439
CALL
Porch Group
PRCH
$1.97B
$60.1K ﹤0.01%
74,900
HLP icon
11440
Hongli Group
HLP
$94.9M
$60.1K ﹤0.01%
+41,154
New +$110K
TPB icon
11441
CALL
Turning Point Brands
TPB
$1.75B
$60K ﹤0.01%
2,600
-7,200
-73% -$175K
PNT
11442
CALL
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$60K ﹤0.01%
9,000
+5,100
+131% +$42.4K
EWH icon
11443
PUT
iShares MSCI Hong Kong ETF
EWH
$1.21B
$60K ﹤0.01%
3,500
+2,600
+289% +$47.9K
DEM icon
11444
PUT
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.97B
$60K ﹤0.01%
1,600
-500
-24% -$19.4K
FLNT
11445
Fluent
FLNT
$129M
$59.9K ﹤0.01%
+22,501
New +$84.2K
PSQH icon
11446
CALL
PSQ Holdings
PSQH
$15.5M
$59.9K ﹤0.01%
+440
New +$78.3K
ASB icon
11447
PUT
Associated Banc-Corp
ASB
$6.11B
$59.9K ﹤0.01%
3,500
-2,300
-40% -$40.5K
IMPP icon
11448
PUT
Imperial Petroleum
IMPP
$217M
$59.9K ﹤0.01%
37,900
+5,444
+17% +$11.2K
DCOM icon
11449
PUT
Dime Commercial Bancshares
DCOM
$1.81B
$59.9K ﹤0.01%
3,000
-9,900
-77% -$207K
SOLO
11450
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
$59.8K ﹤0.01%
+91,318
New +$66.2K

Similar funds

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.